跳至正文

信是真的，数字是真的，标签是真的

目录

机制裁决第 149 篇 · 对称双向第 144 篇 · section H 全球公共卫生第九篇 · 全库第 207 篇 本篇审的是「12 小时神话」这句话——以及它背后那封 101 词的读者来信、那张「every 12 hours」的标签、和整个阿片危机叙事里的数字与归因。先读三句红线：

  1. 本篇不裁决任何疼痛治疗决策、药品政策或诉讼是非，不评价任何公司或个人的动机——只审「12 小时神话」及相关数字从文件里读出来时承重承不承得住。涉及健康风险，只登记公开披露的事实与官方判定，不推断因果。本篇不构成任何用药、处方或治疗建议。
  2. 「Porter & Jick 被误读」与「Porter & Jick 全错」是两件不同的事。本篇的裁决主要落在前者：那封信是真的、信里的数字是真的、但「成瘾在医疗人群中罕见」这句话被从它的语境（住院短期使用、无成瘾史）里拆出来，缝进了 OxyContin 的营销叙事——而「短期使用成瘾低危」这一内核，现代官方数据（CDC/NIDA）至今仍然支持，问题从来不在那个数字，而在语境外推。
  3. 全篇承重句均给出可点击来源；英文逐字引用一律标注取回方式。本篇引用的所有数字（引用次数、成瘾率、死亡人数、罚款金额、处方量）都给出出处，自算部分先复现官方数字校验算法、通过后才使用，算式写进正文，可复现。

零、一句话裁决

「12 小时神话」这个名字是真的——但它指的不是一个小时的谎言，是一段话的旅程：Porter & Jick 1980 那封 101 词读者来信（NEJM 原文 Wayback 快照逐字「Although there were 11,882 patients who received at least one narcotic preparation, there were only four cases of reasonably well documented addiction in patients who had no history of addiction」「We conclude that despite widespread use of narcotic drugs in hospitals, the development of addiction is rare in medical patients with no history of addiction.」[一手逐字]）是真的；OxyContin 1995 年获批时那张「every 12 hours」的标签（FDA 批准信与原始标签逐字「The controlled-release nature of the formulation allows it to be effectively administered every 12 hours」[一手逐字]）是真的；普渡 2007 年认罪（DOJ 新闻稿逐字「misbranding OxyContin…will pay over $600 million」）、2020 年全球和解（$3.544B 罚金 + $2B 没收 + $2.8B 民事 + Sackler $225M）、最高法院 2024 年否决 Sackler 免责（Harrington v. Purdue逐字「The bankruptcy code does not authorize a release and injunction」）都是真的——被读成的一句假话，是把「住院短期使用成瘾罕见」读成「长期处方也安全」，把「12 小时给药间隔」读成「12 小时止疼」，把「处方阿片是危机的第一波」读成「处方阿片是危机的全部」。

而「12 小时」这三个字的旅程本身也是一部可考的档案：1995 年 FDA 批准信（「This new drug application provides for the management of moderate to severe pain in patients where use of an opioid analgesic is indicated for more than a few days」[一手逐字]）→ 1996 年上市（普渡把「12 小时」培训成销售话术，Van Zee 2009 AJPH（PMC 全文）逐字「Purdue has centred its promotional and marketing focus for OxyContin® on the q12h dosing schedule」）→ 2001 年 7 月 FDA 强化标签（FDA 官方时间线逐字：适应症从「more than a few days」改为「around-the-clock…extended period of time」+ Boxed Warning）→ 2016 年 5 月《洛杉矶时报》调查报道《’You Want a Description of Hell?’ OxyContin’s 12-Hour Problem》把「12 小时」从技术参数变成调查对象（原件逐字「The drug wears off hours early in many people」）→ 2016 年 12 月 NIDA CTN 简报第一次把该系列标注为「12-hour myth」——「12 小时神话」不是一篇 NEJM 观点文章命名的（任务书预设的《The “12-Hour Myth”》NEJM 2016 文章经 PubMed/Crossref/NEJM 目录三重检索确认不存在，见第四章），而是调查报道 + 机构简报 + 学术综述（Van Zee/Leung）三方合流的命名。本篇的独占格在第四章（引文考古：101 词读者来信的引用史与 4/11,882 的旅程）、第六章（危机流行病学：三波浪潮的 CDC 官方框架与阶段归因账，含 2024 年死亡数大降 26.2% 的时效账）、第七章（兑现账：2007 认罪 → 2020 全球和解 → 2024 最高法院否决 → 2025-11 破产案新计划获批）与第九章（反向红跳五句审计：含「短期使用成瘾罕见并未全错」的平衡账）。

灵魂句：那封信是真的，那个数字是真的，那张标签是真的——被读成的一句假话，是把「住院、短期、无成瘾史」三个限定词从一句话里拆掉的那个动作。拆掉限定词的不是普渡一家——是引用链（608 篇引用中 80.8% 未注明住院语境，Leung 2017 逐字）、是培训材料（「less than one percent」话术）、是媒体标题、是每一处把 4/11,882 读成「成瘾罕见」的转述。而每个环节的线头，都印在档案里。

一、本篇测什么

1.1 被审对象

被审的是一句话及其用法：

  • 名号句：「12 小时神话」——12 小时给药间隔如何从标签参数变成「神话」
  • 引文句：「Porter & Jick 证明成瘾罕见」（4/11,882 的旅程）
  • 归因句：「OxyContin 造成阿片危机」/「处方阿片是危机的祸首」
  • 兑现句：「危机已被解决」（罚款/和解/指南 = 结束）

1.2 结构胎记

引文跳 × 标签跳 × 归因跳 × 兑现跳 ＋ 反向红跳。

  • 引文跳：把「一封 101 词读者来信（住院短期使用、无成瘾史患者）」读成「一项证明阿片成瘾罕见的长期研究」——Porter & Jick 1980 全文逐字 + 引用史（Leung 2017：608 篇引用、72.2% 肯定式引用、80.8% 未注明住院语境、「heavily and uncritically cited」）+ NEJM 编辑部按语 + Jick 本人表态（「I’m essentially mortified」）+ 误用样本链（Empire of Pain/销售话术/中文转述）。
  • 标签跳：把「12 小时给药间隔（药代动力学参数）」读成「12 小时止疼（疗效承诺）」——1995 原始标签逐字、普渡 q12h 营销话术（Van Zee 逐字「centred its promotional and marketing focus…on the q12h dosing schedule」）、2001-07 FDA 强化、2016 LA Times 调查、药效现实（t½=4.5h、实测中位 9.6h、8 小时失效、「no well-controlled clinical studies」官方锚点）。
  • 归因跳：把「处方阿片是危机的第一波（1990s-2010）」读成「处方阿片是危机的全部/唯一祸首」——CDC 三波浪潮官方框架逐字、处方 vs 海洛因 vs 非法芬太尼的阶段账（处方类死亡率 2010-2021 稳定在 4.0/10 万 vs 合成阿片升至 21.8）、处方量峰值（2012 年 255,207,954 张）与死亡曲线的分离。
  • 兑现跳：把「罚款/和解/指南落地」读成「危机结束」——2007 $634.5M → 2020 $8.3B 全球和解 → 2024 最高法院否决 → 2025-11 新计划获批（Sackler up to $7B/15 年）→ 但 2021-2023 死亡终值仍 10 万+/年（2024 大降 26.2% 是首个真正拐点，写稿时点必须交代）、和解金支出账（2024 年仅支出/承诺 $2.7B、约 20% 无法追踪）。
  • 反向红跳（第九章）：五句反向审计——「短期使用成瘾罕见并未全错」（平衡账：现代证据支持短期低危，但「长期也安全」推论不立）、「阿片危机全是普渡/沙克勒的阴谋」不立（JCAHO/VA「第五生命体征」制度史 + 非法市场阶段）、「处方阿片是唯一祸首」不立（芬太尼阶段）、「危机已解决」不立（曲线分离 + 和解金账）、「止痛治疗回归正常」不立（cautious prescribing 反噬：90 MME 上限被误用为硬性标准、患者被弃诊、2022 指南自我纠偏）。

1.3 落位：全球公共卫生第九篇

本库全球公共卫生家族：抗生素耐药（第 162 篇）、癌症筛查（第 163 篇）、微塑料（第 166 篇）、营养流行病学（第 167 篇）、长新冠（第 170 篇）、维生素 D（第 173 篇）、空气污染（第 182 篇）、PFAS 永久化学品（第 206 篇）——本篇为第九篇。

  • 与 PFAS 篇（206）对照：那篇的名号是「永久化学品」（2018 造词，修辞进词典），本篇的名号是「12 小时神话」（2016 命名，参数变话术）——两篇都是「名号从文件里长出来、被传播链兑换」的形状；那篇的尺子是检出限/监管限/健康线三层，本篇的尺子是「成瘾率（4/11,882）」「给药间隔（12h）」「死亡数（三波浪潮）」三把。
  • 与安慰剂篇分界写死：安慰剂篇的阿片 24 处全为「内源性阿片肽」机制义（疼痛通路的神经科学），本篇的对象是阿片类药物作为商品与危机的社会史——两者不重叠，本篇不重做机制账。
  • 与司法鉴定篇/诉讼主题：2007/2020/2024 诉讼只登记已公开的判决书、认罪协议与和解金额，不推断新动机、不作责任判定。
  • 毒理红线：本篇不构成任何用药、处方或治疗建议；涉及成瘾率、死亡数处只登记官方判定与同行评议证据。

1.4 去重实测

python 全库扫描 206 篇 / 7,564,709 字符：阿片 24 处、阿片类 5 处、opioid 1 处——全部集中在安慰剂篇（2026-06-23），为「内源性阿片肽」机制义；Porter 54 处全部为幂律/统计物理领域别义（Porter 系数等）；Jick/OxyContin/奥施康定/Purdue/普渡（1 处为普渡大学别义）/Sackler/芬太尼/fentanyl/12小时/12 小时/12-hour/处方药（1 处为血清素篇旁注）/成瘾（1 处为微塑料篇旁注）全零命中——专篇零命中，处女地。

1.5 边界

  • 与安慰剂篇：机制义 vs 社会史，不重做。
  • 与 PFAS 篇：名号账同族但对象不同（环境化学 vs 处方药），不重做「检测三层」账。
  • 与司法鉴定篇：诉讼只登记已公开文件。
  • 中国语境：只登记公开的官方文件（芬太尼整类列管公告）与媒体样本，不评价政策。

1.6 方法备案

  • 取证通路：PubMed/E-utilities（Porter & Jick 7350425、Leung 28564561、Van Zee 18799767、Shah 28301454、Barnett 28199807、CDC 2022 指南 36327391、Baker 28241189 全 200）；Wayback id_（NEJM 1980 原件、FDA 时间线、CDC 系、HHS 2017 公告）；supremecourt.gov/DOJ 原件 PDF 直连 200；NEJM 2019 标签/2015 SumR/批准史 accessdata.fda.gov 直连 200；1995 批准信 regulations.gov 直连 200（扫描 OCR 双源互证）；govinfo 众议院听证 200；CDC 系 403（走 Wayback/stacks/archive.cdc.gov）；NEJM 出版版 403（走 PubMed+Wayback）；AJPH 原版 403（以 IJME 2019 再刊版替代）。
  • 承重统计一律 python3（环境 grep 为 ugrep 对部分文件静默失灵）。
  • 已知风险登记：Semantic Scholar 被引数 1084（2026-08-12 抓取）≠ Leung 2017 的 608（截至 2017-03-30 引文分析口径），两数不可直接互比；「12 小时神话」命名考证的权威锚是 LA Times 2016-05-05 系列 + CTN Bulletin 2016-12-21（「NEJM 2016 观点文章」系任务书错误前提）；2024 年死亡数大降（-26.2%）是新数据点，写稿时点必须交代 provisional/final 层级；71,238（2021 芬太尼死亡计数）仅媒体层可证且为临时口径，正文避免直接与终值相除。

二、核验标记与层速览

核验标记沿用本库四档：[一手逐字]＝原文逐字取自实际取回文件（含 Wayback id_ 原件）；[文献较稳]＝多源一致或权威评估；[需亲核]＝正文未全取回或版本存疑；[多源检索]＝方法学阴性检索。

层 名称 核心问题 裁决方向
三 守真锚 原文/判决/标签/数据 一条不动
四 引文考古账 101 词读者来信的旅程 限定词丢失史
五 标签与药理学账 「12 小时」是什么 参数→话术→神话
六 危机流行病学账 三波浪潮与归因 处方是第一波非全部
七 制度与司法账 2007→2020→2024→2025 兑现 金额真、解决未立
八 消费与传播账 「12 小时神话」的命名史 调查报道+机构简报合流
九 反向红跳 五句反向审计 全部不立（含平衡账）
十 母裁决 一句话裁决 见末章

三、守真锚（这一侧一条都不动）

1. Porter & Jick 1980 的信是真的，全文逐字可考。 NEJM 1980;302:123 原文（Wayback id_ 快照 20250512123639，200）逐字「To the Editor: Recently, we examined our current files to determine the incidence of narcotic addiction in 39,946 hospitalized medical patients who were monitored consecutively. Although there were 11,882 patients who received at least one narcotic preparation, there were only four cases of reasonably well documented addiction in patients who had no history of addiction. The addiction was considered major in only one instance. The drugs implicated were meperidine in two patients, Percodan in one, and hydromorphone in one. We conclude that despite widespread use of narcotic drugs in hospitals, the development of addiction is rare in medical patients with no history of addiction.」署名逐字「Jane Porter / Hershel Jick, M.D. / Boston Collaborative Drug Surveillance Program Boston University Medical Center, Waltham, MA 02154」[一手逐字]（PubMed 正确 PMID 7350425——任务书预设 7350609 系 Radiology 论文，勘误）；NEJM 编辑部按语（同页逐字）「For reasons of public health, readers should be aware that this letter has been ‘heavily and uncritically cited’ as evidence that addiction is rare with opioid therapy.」[一手逐字]。

2. OxyContin 1995 年获批，标签上的「12 小时」是真的。 FDA 批准信（NDA 20-553，regulations.gov 扫描件，OCR 双源互证）逐字「This new drug application provides for the management of moderate to severe pain in patients where use of an opioid analgesic is indicated for more than a few days」「the application is approved effective on the date of this letter」[一手逐字]；1995 原始标签 DOSAGE 段逐字「OxyContin is intended for the management of moderate to severe pain in patients who require treatment with an oral opioid analgesic for more than a few days. The controlled-release nature of the formulation allows it to be effectively administered every 12 hours.」[一手逐字]；FDA 2015 批准史逐字「OxyContin is an extended-release formulation of oxycodone that was initially approved December 12, 1995, as 10 mg, 20 mg, and 40 mg tablets, under NDA 20553」[一手逐字]（2019 标签首行「Initial U.S. Approval: 1950」指活性成分 oxycodone 最早获批年份，与本品 1995 首批不冲突——两处并存须注明）。

3. 2007 年普渡认罪是真的。 DOJ USAO-WDVA 2007-05-10 新闻稿（curl 403 → web_extract 200）逐字「THE PURDUE FREDERICK COMPANY, INC. AND TOP EXECUTIVES PLEAD GUILTY TO MISBRANDING OXYCONTIN; WILL PAY OVER $600 MILLION」「Purdue and the three executives will pay a total of $634,515,475.」[一手逐字]；VAWD 法院意见逐字「has pleaded guilty to misbranding OxyContin, a prescription opioid pain medication, with the intent to defraud or mislead, a felony under the federal Food, Drug, and Cosmetic Act」「Purdue has agreed to substantial additional monetary sanctions totaling $600 million, reported to be one of the largest in the history of the pharmaceutical industry.」[一手逐字]（双口径：$634.5M=公司+三名高管 / $600M=公司+关联方，均官方，按上下文引用）。

4. 2020 年 DOJ 全球和解是真的，金额逐字可考。 DOJ 新闻稿（2020-10-21）逐字「The criminal resolution includes the largest penalties ever levied against a pharmaceutical manufacturer, including a criminal fine of $3.544 billion and an additional $2 billion in criminal forfeiture」「Purdue has also agreed to a civil settlement in the amount of $2.8 billion」「the Sackler family has agreed to pay $225 million」「from May 2007 through at least March 2017, Purdue conspired to defraud the United States by impeding the lawful function of the DEA」[一手逐字]；认罪协议逐字「Purdue shall not be subject to a term of probation」「Oxycodone is an opioid agonist 1.5 times more powerful than morphine」[一手逐字]（主语是 Oxycodone 非 OxyContin）；和解协议 Recital 10 逐字「In 2007, The Purdue Frederick Company, Inc.…pled guilty to misbranding OxyContin by falsely marketing it as less addictive, less subject to abuse and diversion, and less likely to cause dependence and withdrawal than other pain medications」[一手逐字]；Sackler 和解逐字「The Named Sacklers shall pay or cause to be paid to the United States two-hundred twenty-five million ($225,000,000)」「Through their approval of the E2E program, from 2013 to 2018, the Named Sacklers knowingly caused the submission of false and fraudulent claims to federal health care benefit programs」[一手逐字]。

5. 2024 年最高法院否决 Sackler 免责是真的。 Harrington v. Purdue Pharma, 603 U.S. ___ (2024)（判决书 PDF）逐字「Between 1999 and 2019, approximately 247,000 people in the United States died from prescription-opioid overdoses」「the Sacklers initiated a ‘milking program,’ withdrawing from Purdue approximately $11 billion—roughly 75% of the firm’s total assets—over the next decade」「the Sacklers proposed to return approximately $4.3 billion to Purdue’s bankruptcy estate」「Held: The bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization under Chapter 11, effectively seek to discharge claims against a nondebtor without the consent of affected claimants.」[一手逐字]；主笔阵容逐字「GORSUCH, J., delivered the opinion of the Court, in which THOMAS, ALITO, BARRETT, and JACKSON, JJ., joined. KAVANAUGH, J., filed a dissenting opinion, in which ROBERTS, C. J., and SOTOMAYOR and KAGAN, JJ., joined.」[一手逐字]；异议句逐字「Today’s decision is wrong on the law and devastating for more than 100,000 opioid victims and their families」「all 50 state Attorneys General have signed on to the plan—a rare consensus.」[一手逐字]。

6. CDC 的三波浪潮框架与死亡账是真的。 CDC《Understanding the Opioid Overdose Epidemic》（Wayback 200）逐字「From 1999-2021, nearly 645,000 people died from an overdose involving any opioid, including prescription and illicit opioids」「This rise in opioid overdose deaths can be outlined in three distinct waves. The first wave began with increased prescribing of opioids in the 1990s, with overdose deaths involving prescription opioids (natural and semi-synthetic opioids and methadone) increasing since at least 1999. The second wave began in 2010, with rapid increases in overdose deaths involving heroin. The third wave began in 2013, with significant increases in overdose deaths involving synthetic opioids, particularly those involving illicitly manufactured fentanyl.」[一手逐字]（任务书预设的 mm675152e1「The first wave began in 1991」句经三版本核验不存在——「1991」仅见于 2011 Vital Signs 基准年与新华社报道，三波框架以本句为准）；死亡终值链（NCHS Data Brief 457/491/522/549，全部 Wayback 200）逐字「In 2021, 106,699 drug overdose deaths occurred」「In 2022, 107,941 drug overdose deaths occurred」「In 2023, 105,007 drug overdose deaths occurred」「In 2024, 79,384 drug overdose deaths occurred…The largest decrease, 26.2%, occurred between 2023 and 2024, from 31.3 to 23.1.」[一手逐字]（任务书「2023 约 107,941」系 2022 终值错贴；109,680 为 2022 临时值——正文一律用终值并注明层级）；处方量账（CDC 处方地图页，Wayback 200）逐字「the total number of prescriptions dispensed peaked in 2012 at more than 255 million and a dispensing rate of 81.3 prescriptions per 100 persons」「in 2020, the dispensing rate had fallen to the lowest in the 15 years…at 43.3 prescriptions per 100 persons (total of more than 142 million opioid prescriptions)」[一手逐字]。

四、引文考古账（101 词读者来信的旅程）

4.1 原件：一封 101 词的信

  • 全文逐字（守真锚 1）：39,946 名连续监测的住院患者 → 11,882 人至少用过一次麻醉药 → 4 例「reasonably well documented addiction」且「no history of addiction」→ 仅 1 例「major」→ 涉药 meperidine×2/Percodan×1/hydromorphone×1 → 结论「the development of addiction is rare in medical patients with no history of addiction」[一手逐字]；
  • 三个限定词：住院（hospitalized medical patients）、短期（monitored consecutively——住院监测）、无成瘾史（no history of addiction）。Leung 2017 逐字「the patients who were described in the letter were hospitalized at the time they received the prescription」[一手逐字]；Juurlink & Dhalla 2012 逐字「very few well-designed studies support the notion that opioid addiction is rare during chronic opioid therapy and that none can be readily generalized to present-day practice. Despite serious methodological limitations, these studies have been repeatedly mischaracterized as showing that the risk of addiction during chronic opioid therapy is rare.」[一手逐字]——「4/11,882」的争议不在数字本身（数字是真的），而在它被用于证明的东西（长期慢性阿片治疗的成瘾率）恰好超出它的测量范围。

4.2 引用史：608 篇与 72.2%

Leung et al. NEJM 2017《A 1980 Letter on the Risk of Opioid Addiction》（web_extract 200；PMID 28564561）逐字：

  • 「The crisis arose in part because physicians were told that the risk of addiction was low when opioids were prescribed for chronic pain. A one-paragraph letter that was published in the Journal in 1980 was widely invoked in support of this claim, even though no evidence was provided by the correspondents」
  • 「We identified 608 citations of the index publication and noted a sizable increase after the introduction of OxyContin (a long-acting formulation of oxycodone) in 1995…the authors of 439 (72.2%) cited it as evidence that addiction was rare in patients treated with opioids. Of the 608 articles, the authors of 491 articles (80.8%) did not note that the patients who were described in the letter were hospitalized…whereas some authors grossly misrepresented the conclusions of the letter」
  • 「In contrast to the 1980 correspondence, 11 stand-alone letters that were published contemporaneously by the Journal were cited a median of 11 times.」
  • 「In conclusion, we found that a five-sentence letter published in the Journal in 1980 was heavily and uncritically cited as evidence that addiction was rare with long-term opioid therapy. We believe that this citation pattern contributed to the North American opioid crisis by helping to shape a narrative that allayed prescribers’ concerns about the risk of addiction associated with long-term opioid therapy.」[一手逐字 ×5]
  • 口径账：Semantic Scholar 被引 1084（2026-08-12 抓取）≠ Leung 的 608（截至 2017-03-30 的引文分析）——608 是「分析样本」不是「总被引数」，正文须注明口径；被引曲线的「OxyContin 拐点」（1995 年后引用大增）是 Leung 的 Figure 1 结论[一手逐字]。

4.3 误用样本链（逐字+层级）

样本 逐字 层级
销售话术（Keefe《Empire of Pain》p.252 复述） 「In fact, a survey of more than 11,000 opioid-using patients, taken over several years, found only four cases of documented addiction」「In truth, the item in the journal was not a peer-reviewed study at all, but a five-sentence letter to the editor」 一级（书籍原文）
普渡培训话术（Van Zee 2009 引 Meier 2003） 「Purdue trained its sales representatives to carry the message that the risk of addiction was ‘less than one percent.’」 一级（PMC 全文）
1997 促销材料（IJME 2019 转述） 「’less than 1% of patients taking opioids actually become addicted’」 二级（学术转述）
被引误读实例（AP 2017） 「’This pain population with no abuse history is literally at no risk for addiction,’ one citation said.」 一级媒体
Jick 本人（AP 2017-05-31） 「I’m essentially mortified that that letter to the editor was used as an excuse to do what these drug companies did」「They used this letter to spread the word that these drugs were not very addictive.」 一级媒体
Jick 宣誓证词（ProMarket 2019 转引） 「We don’t have any information in this letter which relates to these [people taking OxyContin].」 二级（转引证词）
Jick 本人（NPR Marketplace 2023-06-02） 「That letter was used to advertise by new companies that were pushing out new pain drugs…I was sort of amazed. None of the companies came to me to talk to me about the letter, or [its] use as an ad.」 二级（媒体采访）
加州起诉状（People v. Purdue, 2014） 「He also noted that the drug companies used his letter to conclude that opioids are not addictive, ‘[b]ut that’s not in any shape or form what we suggested in our letter.’」 二级（起诉状转述）
中文转述（腾讯/知识分子 2021） 「这个 ‘少于1%’ 的数字是怎么得来的？1979年，波士顿大学医院的赫舍尔·吉克（Hershel Jick）医生一时兴起，想知道在他供职的医院有多少住院病人在服用阿片类止痛药后……」 一级（中文媒体）

「1% 话术」的完整溯源链：1980 信 4/11,882（≈0.03%）→ 普渡 1997 促销材料「less than 1%」→ 销售培训「less than one percent」→ 中文转述「少于 1% 的患者对奥施康定上瘾」（腾讯/知识分子、中国药房 2023「实为营销谎言」、澎湃 2021）——0.03% 到 1% 之间是话术的放大，1% 到「长期使用也安全」之间是语境的丢失（Van Zee 2009 逐字：「Both of these studies, although shedding some light on the risk of addiction for acute pain, do not help establish the risk of iatrogenic addiction when opioids are used for chronic pain.」[一手逐字]）。

4.4 「12 小时神话」命名史：任务书预设纠错

  • 预设纠错（最高优先）：任务书所述「NEJM 2016-11-10《The ’12-Hour Myth’》观点文章」不存在——PubMed "12-Hour Myth"[Title] 零命中、PubMed OxyContin[Title] AND NEJM 仅 1 条（PMID 22784140 非 2016 篇）、Crossref 题名/书目检索零命中、NEJM Vol.375 No.19 目录逐条核对无相关文章、预设 DOI 404[多源检索]；预设 PMID 27959717 实为 NEJM 2017;376:32-40 Ticagrelor 试验（EUCLID）[一手逐字]。
  • 真实命名链：① LA Times 2016-05-05 调查系列第一篇《’You Want a Description of Hell?’ OxyContin’s 12-Hour Problem》（Ryan/Girion/Glover，Wayback 原件 200/392KB）逐字「The drugmaker Purdue Pharma launched OxyContin two decades ago with a bold marketing claim: One dose relieves pain for 12 hours, more than twice as long as generic medications」「But OxyContin’s stunning success masked a fundamental problem: The drug wears off hours early in many people, a Los Angeles Times investigation found.」「Purdue has known about the problem for decades. Even before OxyContin went on the market, clinical trials showed many patients weren’t getting 12 hours of relief.」[一手逐字]；② NIDA CTN Bulletin 2016-12-21 第一次把该系列标注为「Part 1 (12-hour myth)」[摘录级]；③ Van Zee 2009 AJPH（学术源，早于媒体）；④ Leung 2017 NEJM 把 1980 信的误引史定案——「12 小时神话」是调查报道 + 机构简报 + 学术综述三方合流的命名，不是一篇 NEJM 观点文章。
  • LA Times 调查的承重细节：原件逐字「One OxyContin tablet in the morning and one before bed would provide ‘smooth and sustained pain control all day and all night.’」「On the strength of that promise, OxyContin became America’s bestselling painkiller, and Purdue reaped $31 billion in revenue.」「When many doctors began prescribing OxyContin at shorter intervals in the late 1990s, Purdue executives mobilized hundreds of sales reps to ‘refocus’ physicians on 12-hour dosing. Anything shorter ‘needs to be nipped in the bud. NOW!!’ one manager wrote to her staff.」「more than a third of the women given OxyContin started complaining about pain in the first eight hours and about half required more medication before the 12-hour mark, according to an FDA analysis of the study.」[一手逐字 ×5]；CBS News 2016-05-10逐字「In an FDA analysis cited by The Times, one-third of 164 cancer patients taking OxyContin dropped out because the medication was ‘ineffective.’」「Even though some doctors recommended dosing every 8 hours, Purdue continued to market the drug as a 12-hour medication」[一手逐字]。

五、标签与药理学账（「12 小时」是什么）

5.1 标签谱系：1995「more than a few days」→ 2001 收紧 → 2019 现行

  • 1995 获批：批准信逐字「for the management of moderate to severe pain in patients where use of an opioid analgesic is indicated for more than a few days」；原始标签 INDICATIONS 逐字「OxyContin® tablets are a controlled-release oral formulation of oxycodone hydrochloride indicated for the management of moderate to severe pain where use of an opioid analgesic is appropriate for more than a few days」；DOSAGE 逐字「The controlled-release nature of the formulation allows it to be effectively administered every 12 hours」（regulations.gov 扫描件 + jfy 1995 标签双 OCR 互证，重构文本）[一手逐字]；
  • 2001-07 强化：FDA 官方时间线（Wayback 200）逐字「July: Additional stronger warnings about the potential for misuse and abuse were added to the OxyContin label.」「the indication for using the drug was changed from ‘moderate to severe pain where use of an opioid analgesic is needed for more than a few days’ to ‘management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.’」「A Boxed Warning was added…Purdue Pharma, agreed to implement a Risk Management Program (RMP)」[一手逐字]；govinfo 众议院听证（2001-07-25）逐字「On July 25, 2001, the FDA announced that, in cooperation with Purdue Pharma, it was strengthening the warning and precautions section in the labeling of OxyContin. The changes include a ‘black box warning,’ the strongest type of warning for an FDA-approved drug」[一手逐字]（FDA 公告日为 2001-07-25 非任务书常见 7-13）；HHS Jenkins 声明（Wayback 200）逐字「In July 2001, Purdue Pharma, working in cooperation with FDA, significantly strengthened the warnings and precautions sections in the labeling for OxyContin…The indication for use was clarified to reflect that it is approved for the treatment of moderate to severe pain in patients who require around the clock narcotics for an extended period of time.」[一手逐字]；
  • 2019 现行标签：022272s043lbl（直连 200）逐字「Initial U.S. Approval: 1950」「OXYCONTIN exposes users to risks of addiction, abuse and misuse, which can lead to overdose and death」「OXYCONTIN is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment」「OXYCONTIN is administered orally every 12 hours」[一手逐字 ×4]（盒装警告标题实为七项要素，非常见「五要素」表述——以实际标题为准）——1995「more than a few days」到 2019「daily, around-the-clock, long-term」的适应症措辞演化，就是「12 小时」从参数变成承诺再变成监管锚点的档案。

5.2 药理学账：t½=4.5 小时与「设计目标」

  • 2019 标签 12.3 Pharmacokinetics（直连 200）逐字「OXYCONTIN is designed to provide delivery of oxycodone over 12 hours」「The apparent elimination half-life (t½) of oxycodone following the administration of OXYCONTIN was 4.5 hours compared to 3.2 hours for immediate-release oxycodone」「In a study comparing 10 mg of OXYCONTIN every 12 hours to 5 mg of immediate-release oxycodone every 6 hours, the two treatments were found to be equivalent」[一手逐字]——12 小时是「设计目标」（designed to），不是药代必然：t½ 4.5 小时约为给药间隔的三分之一；
  • 官方自我限定句（本篇最重一格）：2019 标签逐字「There are no well-controlled clinical studies evaluating the safety and efficacy with dosing more frequently than every 12 hours.」[一手逐字]——FDA 标签明文承认：没有良好对照研究评估过比 12 小时更频繁给药的疗效与安全——「12 小时」的完整证据空白由官方自己写在自己的标签里；
  • 辩护方自认（层级最高对照）：Fudin & Raouf, J Pain Res 2016《OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form》（PMC 200；注意此文立场为辩护 12 小时给药，引用须注明）逐字「In a survey of 128 patients on stable doses of oxycodone CR for 6 months, clinicians evaluated the frequency of IR opioid use in patients on 12-hour and 8-hour dosing. The authors concluded that patients on 12-hour dosing were twice as likely to use scheduled IR opioids to achieve pain relief.」「patients reported average pain relief duration of 9.6 hours」「some patients may experience end-of-dose failure with a 12-hour regimen.」[一手逐字]——12h 组补救药使用率是 8h 组两倍、实测平均止痛时长 9.6 小时（<12h）、剂量末期失效——连为 12 小时辩护的论文都逐字承认；
  • 药效现实的其他锚点：Van Zee（IJME 2019 版）逐字「In various studies, OxyContin® did not consistently relieve pain for the entire 12-hour dosing interval and many patients required ‘rescue medication’」「During the 1999 patent trial, Dr. Robert F. Kaiko, OxyContin’s inventor, acknowledged that he had no evidence to support 12-hour efficacy」「Sunshine et al. determined that the median effective dose interval for OxyContin® occurred at 10 hours」[一手逐字]；Bodie v. Purdue（11th Cir. 判词转述原告主张）逐字「Bodie alleged that the 12-hour dosage frequency recommended by Purdue was intentionally designed to lead to addiction in patients…the drugs’s ameliorative effects wore off before the 12-hour period was complete」[一手逐字]（原告指控转述，非法院事实认定）；LA Times 逐字「’Is it just me or does oxycontin not even last 8 hours’」（患者留言板引语标题化，2004）[一手逐字]。

5.3 「12 小时止疼」话术的营销档案

Van Zee 2009 AJPH（PMC 全文，直连 200）逐字；以下 q12h 营销论述段（1998 预算案/Kaiko 证词）引自 Van Zee 文 2019 年 IJME 再刊版（作者本人更新再刊；AJPH 原版付费墙 403，正文注明版本）：

  • 「When Purdue Pharma introduced OxyContin in 1996, it was aggressively marketed and highly promoted. Sales grew from $48 million in 1996 to almost $1.1 billion in 2000.」
  • 「Purdue has centred its promotional and marketing focus for OxyContin® on the q12h dosing schedule…’unlike short-acting pain medications, which must be taken every 3 to 6 hours—often on an ‘as-needed basis,’ OxyContin® tablets are taken every 12 hours, providing smooth and sustained pain control all day and all night’」
  • 「Purdue’s 1998 OxyContin® Budget Plan describes the importance of q12 dosing to sales: ‘Our marketing research indicates that the most important feature of OxyContin® tablets, beyond the familiarity of oxycodone, is the q12h dosing schedule. In all seven pre-launch market research projects, healthcare professionals stated that this is the most compelling reason to prescribe the OxyContin® tablets’」
  • 「Purdue told physicians that if their patients weren’t experiencing twelve hours of pain relief, they should increase the q12 dose as a response to pain breakthrough.」
  • 「In July 2001, to reflect the available scientific evidence, the label was modified to state that data were not available for establishing the true incidence of addiction in chronic-pain patients.」[一手逐字 ×5]
  • 营销话术的内部定量：普渡医药代表 1996 年 318 人 → 2000 年 671 人（新华社 2018-06-21 转述人民日报，（原文 2018-06-21 已下线，Wayback 无快照——以 E 捆落盘原件为准）逐字「其医药代表队伍从1996年的318人增至2000年的671人，最高时曾超过1000人」[一手逐字]）；2001 年营销支出（Van Zee 逐字「In 2001 alone, the company spent $200 million in an array of approaches to market and promote OxyContin」[一手逐字]）。

六、危机流行病学账（三波浪潮与阶段归因）

6.1 三波浪潮：官方框架逐字

CDC《Understanding the Opioid Overdose Epidemic》（Wayback 200，守真锚 6）三波逐字「The first wave began with increased prescribing of opioids in the 1990s…The second wave began in 2010, with rapid increases in overdose deaths involving heroin. The third wave began in 2013, with significant increases in overdose deaths involving synthetic opioids, particularly those involving illicitly manufactured fentanyl.」[一手逐字]；MMWR 2018;67(12):349-358（Wayback 200）逐字「The first wave of opioid overdose deaths began in the 1990s and included prescription opioid deaths. A second wave, which began in 2010, was characterized by heroin deaths. A third wave started in 2013, with deaths involving highly potent synthetic opioids, particularly IMF and fentanyl analogs.」[一手逐字]——三波框架的两处官方逐字（官方页与 MMWR 正刊）完全同构；「1991」作为处方死亡率基准年仅见于 MMWR 2011 Vital Signs（逐字「The death rate of 11.8 per 100,000 population in 2007 was roughly three times the rate in 1991」[一手逐字]）与新华社报道，不是三波起点的官方措辞。

6.2 死亡账：645,000 累计与逐年终值

  • 累计：CDC 官方页逐字「From 1999-2021, nearly 645,000 people died from an overdose involving any opioid, including prescription and illicit opioids」[一手逐字]（口径=「任何阿片」（处方+非法合计），不是「处方阿片」——任务书预设口径勘误）；MMWR 2020逐字「During 1999–2018, opioids were involved in 446,032 deaths in the United States.」[一手逐字]；最高法院判决书口径逐字「Between 1999 and 2019, approximately 247,000 people in the United States died from prescription-opioid overdoses」[一手逐字]——三个累计数三把尺：处方阿片 24.7 万（判决书）/ 阿片合计 44.6 万（2018 止）/ 阿片合计 64.5 万（2021 止），引用必须带口径；
  • 逐年终值（NCHS Data Brief 457/491/522/549，全部 Wayback 200）：2021 年 106,699（「resulting in an age-adjusted rate of 32.4 per 100,000」）→ 2022 年 107,941（32.6）→ 2023 年 105,007（31.3，「decreased 4.0% between 2022 and 2023」）→ 2024 年 79,384（23.1，「The largest decrease, 26.2%, occurred between 2023 and 2024」）[一手逐字 ×4]——2024 是二十年来首次大幅回落（-26.2%），写稿时点（2026-08）必须交代：2023 年死亡数仍比 2019（70,630，同表逐字）高约 49%，2024 才回到 2014 年水平附近（14.7→23.1 仍高于 2014）；任务书「2023 约 107,941」系 2022 终值错贴、「109,680」为 2022 预测临时值（NCHS 博客 2023-05-18逐字「the predicted number of drug overdose deaths showed an increase of 0.5%…from 109,179 to 109,680」[一手逐字]）——正文一律终值口径并注明 provisional/final 层级；
  • 「破十万」节点：NCHS 2021-11-17（Wayback 200）逐字「there were an estimated 100,306 drug overdose deaths in the United States during 12-month period ending in April 2021, an increase of 28.5%」[一手逐字]——美国 12 个月滚动过量死亡首次破十万（截至 2021-04）；
  • 芬太尼占比：2021 年合成阿片死亡计数 71,238 仅媒体层可证（NBC News 2022-05-11 引 NCHS「fentanyl…was involved in the most overdose deaths in 2021: 71,238」[需亲核——临时口径]）；官方比率侧（db457）逐字「The rate of drug overdose deaths involving synthetic opioids other than methadone increased 22%, while the rate of deaths involving heroin declined 32% between 2020 and 2021.」[一手逐字]——正文用官方比率 + 注明计数为临时媒体层。

6.3 处方量账：255,207,954 张与 -44%

CDC 处方地图页（Wayback 2021 快照 200）逐字「After a steady increase in the overall national opioid dispensing rate starting in 2006, the total number of prescriptions dispensed peaked in 2012 at more than 255 million and a dispensing rate of 81.3 prescriptions per 100 persons」「The overall national opioid dispensing rate declined from 2012 to 2020, and in 2020, the dispensing rate had fallen to the lowest in the 15 years, for which we have data at 43.3 prescriptions per 100 persons (total of more than 142 million opioid prescriptions)」[一手逐字]；逐年表逐字（2012 → 255,207,954 张/81.3；2019 → 153,260,450/46.7；2020 → 142,816,781/43.3）[一手逐字]；MMWR 2017（Wayback 200）逐字「annual opioid prescribing rates increased from 72.4 to 81.2 prescriptions per 100 persons from 2006 to 2010, were constant from 2010 to 2012, and then decreased by 13.1% to 70.6 per 100 persons from 2012 to 2015」[一手逐字]（81.2 为 MMWR 口径、81.3 为地图页精确值——两处并存注明）——自算复现：255,207,954 → 142,816,781 = -44.0%（(142816781-255207954)/255207954 = -0.4403，正文注明计算）；「处方量峰值后下降」官方句（mm6911a4）逐字「The number of filled opioid prescriptions peaked in 2012 and decreased thereafter」[一手逐字]。

6.4 归因账：阶段责任

  • 1999-2010 处方驱动：MMWR 2017逐字「Prescription opioid–related overdose deaths increased sharply during 1999–2010 in the United States in parallel with increased opioid prescribing.」[一手逐字]；MMWR 2011逐字「OPR now account for more overdose deaths than heroin and cocaine combined.」「In 2008, a total of 36,450 deaths were attributed to drug overdose…OPR were involved in 14,800 (73.8%) of the 20,044 prescription drug overdose deaths.」[一手逐字]——第一波（1990s-2010）确实由处方阿片主导，这是官方逐字；
  • 2020-2021 阶段切换：CDC 流行病学页逐字「From 2020 to 2021: Opioid-involved death rates increased by over 15%. Prescription opioid-involved death rates remained the same. Heroin-involved death rates decreased nearly 32%. Synthetic opioid-involved death rates (excluding methadone) increased over 22%.」「The market for illicitly manufactured fentanyl continues to change, and it can be found in combination with heroin, counterfeit pills, and cocaine.」[一手逐字]；db457逐字「The age-adjusted rate of drug overdose deaths involving natural and semisynthetic opioids, which includes drugs such as oxycodone and hydrocodone, increased from 1.2 in 2001 to 3.5 in 2010, then did not change significantly from 2010 through 2021 where the rate remained at 4.0 in 2020 and 2021.」[一手逐字]——处方类死亡率 2010-2021 稳定在 4.0/10 万不变，同期合成阿片率升至 21.8/10 万（+22%）——「处方是唯一祸首」与官方曲线直接冲突；
  • NIDA 起源叙事：NIDA《Opioid Overdose Crisis》（Wayback 2022 快照 200）逐字「In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. This subsequently led to widespread diversion and misuse of these medications before it became clear that these medications could indeed be highly addictive.」「About 80 percent of people who use heroin first misused prescription opioids.」[一手逐字]——「80% 海洛因使用者先滥用处方阿片」是处方→非法过渡的关键统计（注意：这反过来证明处方阿片是非法阶段的入口，但不等于处方是全部阶段的唯一驱动）。

6.5 中国语境

  • 芬太尼整类列管：公安部/卫健委/药监局联合公告（2019-04-01 发布，2019-05-01 施行）（新华社通稿 + 国新办发布会实录，直连/Wayback 200）逐字「近日，公安部、国家卫生健康委、国家药监局联合发布公告，宣布从5月1日起将芬太尼类物质列入《非药用类麻醉药品和精神药品管制品种增补目录》」「这标志着中国政府已正式整类列管芬太尼类物质，这是中国禁毒法制建设历程中的重大创新性举措」[一手逐字]；
  • 中美消耗对照：PubMed 31759032（直连 200）逐字「The annual consumption of opioid analgesics in the U.S. was more than 10 times the world average, whereas that in China was at a moderate level within Asia but much lower than the worldwide average」「The adequacy of consumption measure of mainland China ranged from 0.0041 to 0.0088 during 2006-2016, which was less than 1% of that in the reference countries.」[一手逐字]——中美镜像：美国过度使用（世界均值 10 倍+）vs 中国使用不足（参照国 1% 以下）——「阿片危机」是美国现象，中国语境是另一个方向的问题（镇痛不足），正文须注明这一不对称；
  • 中国媒体三波叙事：新华社 2023-09-20《「甩锅」中国解决不了美国「毒祸」》（央视网转载，直连 200）逐字「美国人口仅占世界5%，却消费了全球80%的阿片类药物」「事实上，美国社会的阿片类药物滥用问题已经发生过三波，芬太尼只是第三波的『主角』。第一波滥用潮始于1991年左右，当时一些制药公司投入大量资金资助相关专家和机构，兜售『阿片类药物无害论』」「2019年5月，中方在全球范围内率先整类列管芬太尼类物质」[一手逐字]——新华社三波叙事（1991 年左右起点）与 CDC 官方（1990s）的细微差异是中美叙事对照样本（已登记）。

七、制度与司法账（2007 认罪 → 2020 全球和解 → 2024 最高法院 → 2025 破产案）

7.1 2007：$634.5M 认罪

DOJ USAO-WDVA 新闻稿（web_extract 200）逐字「Purdue and the three executives will pay a total of $634,515,475.00. Purdue’s payments will include: $276.1 million forfeited to the United States; $160 million paid to federal and state government agencies to resolve liability for false claims…$130 million set aside to resolve private civil claims」「Purdue will pay the maximum statutory criminal fine of $500,000.」[一手逐字]；VAWD 法院意见逐字「pled guilty to misbranding OxyContin, a prescription opioid pain medication, with the intent to defraud or mislead」「$600 million, reported to be one of the largest in the history of the pharmaceutical industry」[一手逐字]；USA Today 2007-05-10（直连 200）逐字「helping spark what the Justice Department describes as ‘one of our nation’s greatest prescription drug failures.’」[一手逐字]——2007 案金额双口径（$634.5M 含高管 / $600M 公司侧）均官方；任务书预设的 DEA 新闻稿「largest single criminal fine ever paid by a pharmaceutical company」原句在已取回文件中未出现（登记：该措辞来源待考，正文不用）。

7.2 2020：全球和解的金额账

守真锚 4 全链 + 补：认罪协议逐字「(1) FINE: The sentence imposed shall order a criminal fine in the amount of $3,544,000,000; (2) FORFEITURE: Purdue consents to the entry of a forfeiture judgment in the amount of $2,000,000,000…(4) PROBATION: Purdue shall not be subject to a term of probation.」[一手逐字]（$8.3B 口径 = 罚金 35.44 亿 + 没收 20 亿 + 民事 28 亿；媒体常见「$8.3 billion」即此合计）；Practice Fusion 回扣段（认罪协议事实基础 ¶8）逐字「from April 2016 through December 2016, Purdue paid kickbacks to Practice Fusion, an electronic health records company (‘EHR’), to induce it to recommend and arrange for prescriptions of opioids by creating alerts that would appear within Practice Fusion’s software while providers were seeing patients.」[一手逐字]；E2E/25 倍段（和解协议 ¶5）逐字「At the center of these strategies was Purdue’s aggressive marketing program that focused on detailing over 100,000 doctors and nurse practitioners nationwide each year…By 2013, Purdue intensified its detailing of the very highest-volume prescribers, i.e., those writing ’25 times as many OxyContin scripts’ as their similarly situated peers…This strategy was referred to as the ‘Evolve to Excellence’ or ‘E2E’ program.」[一手逐字]（任务书「Paragraph 9/25」编号勘误：医学上不必要处方段实为 ¶5）。

7.3 2024：最高法院的 5-4

守真锚 5 全链。附加两点：①主文细节逐字「Between 2008 and 2016, the family’s distributions totaled approximately $11 billion, draining Purdue’s total assets by 75% and leaving it in ‘a significantly weakened financial’ state.」[一手逐字]；②Kavanaugh 异议的「plan 支持度」逐字「The plan then guaranteed substantial and equitable compensation to Purdue’s many victims and creditors, including more than 100,000 individual opioid victims.」「Without releases, there will be no $5.5 to $6 billion settlement payment to the estate, and ‘there will be no viable path to any victim recovery.’」[一手逐字]——8-1 或 9-0 的常见转述均不准确：实际是 5-4（Gorsuch 主笔获 Thomas/Alito/Barrett/Jackson 联署；Kavanaugh 异议获 Roberts/Sotomayor/Kagan 联署）。

7.4 2025：破产案新计划获批（时效账）

  • Reuters 2025-11-14（web_extract，T2）逐字「A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.S. opioid epidemic through the sale of addictive pain medications like OxyContin.」[需亲核（web_extract 未落盘，以 11-18 原件为准）]；
  • AP 2025-11-18（经 PBS 全文转载，直连 200 落盘）逐字「A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the harms of opioids」「U.S. Bankruptcy Judge Sean Lane gave reasoning Tuesday for approving the plan, which requires members of the Sackler family who own the company to contribute up to $7 billion over 15 years. Most of the money is to go to government entities to fight the opioid crisis that has been linked to 900,000 deaths in the U.S. since 1999.」「Under the current agreement, entities that do not opt into the payments can still sue members of the family.」「The plan calls for Purdue to be replaced with a new company, Knoa Pharma, to be controlled by a board appointed by states and with a mission of benefiting the public.」「About $850 million of that is to go to individual victims, including children born with opioid withdrawal.」[一手逐字 ×5]；AP 原件（直连 200）逐字「The opioid crisis has been linked to more than 900,000 deaths in the U.S. since 1999.」[一手逐字]——2025-11 新计划：Sackler 出资 up to $7B/15 年（AP/PBS 口径；Bloomberg 称 ~$6.5B 实际分期，T3 未落盘）、未 opt-in 者仍可起诉（与 2024 被否计划的关键区别）、普渡更名为 Knoa Pharma、$850M 个人受害者；普渡官网停业公告（直连 200）逐字「On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma.」[一手逐字]——2026-05-01 普渡永久停业：这个品牌的历史在这一天结束，但危机叙事与和解金的执行仍在继续。

7.5 州级诉讼与全国和解框架

  • Oklahoma v. J&J（AP 2019-11-15）（web_extract 200）逐字「An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million…on Friday reduced that amount in his final order in the case by $107 million because of his miscalculation.」「In it, Balkman acknowledged that he miscalculated in his original award how much it would cost to develop a program for treating babies born dependent on opioids. The cost should have been $107,000 not $107 million.」[一手逐字]——$572M 初判已被终局 $465M 取代（法官自纠 $107M→$107,000 计算错误）——正文凡引 $572M 必须注明；
  • 全国框架（加州 AG 2021-07-21）（web_extract 200）逐字「a historic $26 billion settlement…The settlement includes Cardinal, McKesson, and AmerisourceBergen – the nation’s three major pharmaceutical distributors – and Johnson & Johnson」「The three distributors will collectively pay up to $21 billion over 18 years; Johnson & Johnson will pay up to $5 billion over nine years」[一手逐字]；Reuters 逐字「The deal represents the second-largest cash settlement ever, trailing only the $246 billion tobacco agreement in 1998.」[一手逐字]（任务书「2021-11」勘误：宣布日为 2021-07-21）；
  • 四家全国和解（加州 AG 2023-06-09）（web_extract 200）逐字「Opioid manufacturers Allergan and Teva have committed to move forward with settlements for up to $2.37 billion and $4.25 billion, respectively」「Chain pharmacies CVS and Walgreens also committed…up to $5 billion and $5.7 billion, respectively」[一手逐字]（任务书「Teva $5.7B」勘误：$5.7B 是 Walgreens，Teva 为 $4.25B）。

八、消费与传播账（「12 小时神话」的命名史与叙事）

8.1 命名史三节点（任务书预设纠错后）

① LA Times 2016-05-05（守真锚见 4.4）——调查报道把「12 小时」从营销参数变成调查对象；② NIDA CTN Bulletin 2016-12-21——「Part 1 (12-hour myth)」第一次把该系列标注为「神话」[摘录级]；③ 学术定案：Van Zee 2009（AJPH/IJME）+ Leung 2017（NEJM）——「12 小时神话」= 调查报道命名 + 机构简报标注 + 学术综述定案，三方合流；反方样本：Fudin & Raouf, J Pain Res 2016《OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form》（辩护方标题逐字）[一手逐字]——「12 小时」是「神话」还是「正当批准」，两派标题并存于 2016 年。

8.2 大标题谱系（2017-2026，逐字）

日期 标题/句（逐字） 层级
2017-10-26 HHS 官方稿「HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis」「Each day, according to the Centers for Disease Control and Prevention, more than 140 Americans die from drug overdoses, 91 specifically due to opioids」 一级
2017-10-26 AP「Trump declares US opioid emergency but pledges no new money」「a scourge that kills nearly 100 people a day」 一级
2017-10-26 NBC「Trump Calls Opioids ‘Worst Drug Crisis in American History’」「64,000 Americans died from overdoses last year — 175 every day, seven every hour」 一级
2017-10-26 NPR「Trump Declares Opioid Crisis A Public Health Emergency」+ 特朗普原话「I am directing all executive agencies to use every appropriate emergency authority to fight the opioid crisis.」 一级
2022-05-11 AP「US overdose deaths hit record 107,000 last year, CDC says」「The provisional 2021 total translates to roughly one U.S. overdose death every 5 minutes.」 一级
2022-12-22 AP「Final tally: Nearly 107,000 US overdose deaths last year」「The official number was 106,699」 一级
2024-05-15 [ABC/STAT]「U.S. drug overdose deaths fell for first time in five years」「Last year saw 107,543 U.S. drug overdose deaths」 摘录级
  • 换算链的传播命运：「every 15 minutes」（2015 口径，VUMC逐字「In 2015, every 15 minutes one American died from an opioid related overdose」[一手逐字]）→「every 5 minutes」（2021 口径，AP）→ 中文版「每天坠毁一架波音737客机且无生还」（新华社 2023-09-26逐字，转述《华盛顿邮报》记者）[一手逐字]——三种换算各自有年份口径，传播链里常被混用。

8.3 中文叙事样本（2017-2026，逐字）

媒体 日期 关键句（逐字）
[人民日报/新华社]（2018-06-21 原文已下线） 2018-06-21 《美国「阿片危机」暴露社会痼疾》「开发出了对羟考酮的缓释技术（使得药效在体内缓慢释放，最长药效可达12小时），为这个阿片类药物起了一个全新的商品名——奥施康定」「其医药代表队伍从1996年的318人增至2000年的671人」
澎湃新闻 2021-12-21 《〈成瘾剂量〉：美国版〈人民的名义〉》「当药物的效果证明不会持续12小时时，患者的不适被重新命名为『突破性疼痛』，解决方案是『剂量加倍』」
腾讯/知识分子 2021-06-23 「如何回答医生关于奥施康定成瘾性的问题（标准答案是『少于1%的患者对奥施康定上瘾』）」「这个『少于1%』的数字是怎么得来的？1979年，波士顿大学医院的赫舍尔·吉克（Hershel Jick）医生一时兴起」
丁香园 2016-06-17 「它可以实现 1 小时内快速止痛，12 小时持续镇痛的效果」「关于奥施康定 12 小时持续镇痛的用法已得到了美国 FDA…和 CFDA…的批准」（非批判性对照样本）
新华社 2023-09-26 《美国：底层「嗑药不停」 上层「捞金不止」》「人口不到世界5%的美国，消费了全球80%的阿片类药物」「这相当于『每天坠毁一架波音737客机且无人生还』」
中国日报 2024-08-15 「奥施康定却导致700万人成瘾，50万人死亡」（数字口径与新华社/1905 电影网不一致，并表须注明出处）

中文叙事结构观察：①「12 小时」在中文语境最早作为产品技术特征书写（人民日报 2018），批判性转述（澎湃 2021）晚于英文五年；②「成瘾率 1%」的溯源链在中文媒体（腾讯/知识分子 2021）被完整写出来了——Jick 信 → 普渡话术；③中美镜像（美国过度使用 vs 中国镇痛不足）在中文报道中很少被并置；④影视（《成瘾剂量》《止痛药》《疼痛帝国》书）是中文叙事的主要载体（新华社 2023-09-26 逐字「美国调查记者帕特里克·基夫2021年推出《疼痛帝国》一书，揭露了萨克勒家族与普渡制药公司引发阿片类药物滥用潮」「彼得·伯格的网剧《止痛药》一经推出后就成为奈飞公司平台上最受美国人欢迎的网剧之一」[一手逐字]）。

8.4 利益方叙事对照（逐字）

  • 普渡官方（现态）：purduepharma.com（2026-08 直连 200）逐字「On May 1, 2026, Purdue Pharma permanently ceased operations. Knoa Pharma, a new and different company, will distribute medicines formerly distributed by Purdue Pharma.」[一手逐字]——普渡本尊的「deeply sorry」式道歉句在现网已不存在（2026-05-01 停业），最接近的官方道歉是 Sackler 家族句（下一行）；
  • Sackler 家族（Mortimer 分支，2021-09-01）：Business Wire（web_extract 200）逐字「It distresses us greatly that it also became involved in suffering from addiction or abuse. We are truly sorry for the suffering and loss people have experienced and recognize the anger or hurt that many people have felt alongside their grief.」「While we dispute the allegations that have been made about our family, we have embraced this path in order to help combat a serious and complex public health crisis.」[一手逐字]；
  • David Sackler 国会听证（2020-12-17）：AP（直连 200）逐字「’I want to express my family’s deep sadness about the opioid crisis,’ David Sackler…said」「OxyContin is a medicine that Purdue intended to help people, and it has helped, and continues to help, millions of Americans.」[一手逐字]；PBS（直连 200）导语逐字「Two of the owners of the company that makes OxyContin acknowledged to a congressional committee on Thursday that the powerful prescription painkiller has played a role in the national opioid crisis but stopped short of apologizing or admitting wrongdoing.」[一手逐字]——「深感悲痛」与「止步于道歉」在同一场听证会并存（PBS 导语逐字）；
  • 反方观点（非单一归因论）：AEI Sally Satel《The Myth of What’s Driving the Opioid Crisis》（直连 200）逐字「I have also watched a false narrative about this crisis blossom into conventional wisdom: The myth that the epidemic is driven by patients becoming addicted to doctor-prescribed opioids」「Within the past several years, overdose deaths are overwhelmingly attributable not to prescription opioids but to illicit fentanyl and heroin.」[一手逐字]；Cato《Overdosing on Regulation》2019（web_extract 200）逐字「We find little support for this view. We instead suggest that the opioid epidemic has resulted from too many restrictions on prescribing, not too few.」[一手逐字]；America Magazine 2018-05-17（直连 200 落盘）逐字「In the late 1990s and into the 2000s, prescription opioids were indeed the main cause of overdose deaths…but today the drivers are heroin and, even more, fentanyl, a synthetic opioid that is 50 times as potent as heroin.」[一手逐字]——「神话」一词被两派使用：主流用「12 小时神话」（营销话术），AEI 用「处方驱动神话」（主流叙事）——同一个词，两把剑；
  • 影视：《Dopesick》（2021-10-13 Hulu 首播，8 集，改编 Beth Macy 书；Wikipedia REST 逐字）「Based on the non-fiction book Dopesick: Dealers, Doctors, and the Drug Company that Addicted America by Beth Macy」[一手逐字]；《Painkiller》（2023 Netflix，改编 Keefe《The Family That Built an Empire of Pain》+ Barry Meier《Pain Killer》；Wikipedia REST 逐字）「the series focuses on the birth of the opioid crisis, with an emphasis on Purdue Pharma」[一手逐字]；《The Crime of the Century》（2021 HBO，Alex Gibney 导演，Wikipedia REST 逐字）「The film follows the opioid epidemic in the United States, and the political operatives, government regulations and corporations that enable the abuse of opioids, particularly the Sackler family and Purdue Pharma.」[一手逐字]；《Empire of Pain》（Keefe 2021，Wikipedia REST 逐字）「The book examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the family’s central role in the opioid epidemic.」[一手逐字]。

九、反向红跳（对称审计）

反方一：「短期使用成瘾罕见并未全错——Porter & Jick 被冤枉了」——部分成立，但正是这个「部分」拆掉了整条推论。 现代证据确实支持「短期使用成瘾低危」：Shah 2017（MMWR 66(10):265-269——任务书「JAMA Internal Medicine」勘误，PMID 28301454）（PMC 全文级）逐字「A total of 1,294,247 patients met the inclusion criteria, including 33,548 (2.6%) who continued opioid therapy for ≥1 year」「the probability of continued opioid use at 1 year was 6.0% and at 3 years was 2.9%…with a median time to discontinuation of 7 days」「increased to 13.5% for persons whose first episode of use was for ≥8 days and to 29.9% when the first episode of use was for ≥31 days」「approximately 1 in 7 persons who received a refill or had a second opioid prescription authorized were on opioids 1 year later」[一手逐字 ×4]——同一研究里「低危」与「阶梯跃升」并存：1 天起 6.0%，≥8 天 13.5%，≥31 天 29.9%，长作用型起始 27.3%；NIDA 官方（直连 200）逐字「When properly managed, short-term medical use of opioid pain relievers—taken for a few days following oral surgery, for instance—rarely leads to an opioid use disorder or addiction. But regular (e.g., several times a day, for several weeks or more) or longer-term use of opioids can lead to dependence…and, in some cases, addiction」[一手逐字]——NIDA 的官方句自带转折：short-term rare 与 longer-term risk 在同一句里；Barnett 2017（NEJM 376(7):663-673——任务书「663-671」勘误，PMID 28199807）逐字「rates of opioid prescribing varied widely between low-intensity and high-intensity prescribers (7.3% vs. 24.1%)」「Long-term opioid use was significantly higher among patients treated by high-intensity prescribers than among patients treated by low-intensity prescribers (adjusted odds ratio, 1.30; 95% confidence interval, 1.23 to 1.37)」[一手逐字]——急诊处方不是中性事件：同一医院内医生开方强度差 3 倍以上，患者长期使用概率随之显著上升；Juurlink & Dhalla 2012 逐字（第四章 4.1）「very few well-designed studies support the notion that opioid addiction is rare during chronic opioid therapy」[一手逐字]——平衡账结论：Porter & Jick 的「住院短期」语境没错、现代数据也支持短期低危；错的是把短期低危外推到长期处方的那个动作——而正是这个动作，Leung 2017 证明发生在 608 篇引用中的 72.2%。

反方二：「阿片危机全是普渡/沙克勒的阴谋」——不立（不当行为有据，但多因素系统有据）。 不当行为侧（全部已公开文件）：2007 认罪（「with the intent to defraud or mislead」[一手逐字]）、2020 认罪协议（2007-2017 阻碍 DEA + Practice Fusion 回扣 + E2E「25 倍」[一手逐字]）、参议院/州诉讼记录；多因素侧：VA 1999「疼痛=第五生命体征」全国行动（直连 200）逐字「In January 1999, the Department of Veterans Affairs (VA) took the lead in pain management by launching a nationwide effort to reduce pain and suffering for the 3.4 million veterans who use VA health care facilities」「Doctors and nurses throughout VA’s 1,200 sites of medical care are required to treat pain as a ‘fifth vital sign’」[一手逐字]——联邦最大卫生系统在普渡营销高峰前就把疼痛筛查制度化；JCAHO 2001 疼痛标准（Baker 2017 JAMA）（直连 200）逐字「In 2000…The Joint Commission…introduced standards for organizations to improve care for patients with pain」「The 2001 example of implementation that said ‘Pain is considered a ‘fifth’ vital sign in the hospital’s care of patients’ was changed in 2002 to say ‘Pain used to be considered the fifth vital sign,’ and by 2004 this phrase was deleted from the accreditation standards manual」[一手逐字]——「第五生命体征」是制度史事实（且 2002 即被修改、2004 删除），不是普渡阴谋的产物；opiophobia 文献（Bennett & Carr 2002）逐字「the panel members concluded that irrational fear of the drugs often impedes their appropriate use」[一手逐字]；非法市场阶段（第六章 6.4：三波框架第二/三波由海洛因与非法芬太尼驱动，处方类死亡率 2010-2021 稳定 4.0）——「全是阴谋」把「公司不当行为」与「多因素系统」缝成一句话；两件事都是真的，且方向相反。

反方三：「处方阿片是危机的唯一祸首」——不立。 db457 官方逐字（6.4）：处方类（天然/半合成，含 oxycodone/hydrocodone）死亡率「increased from 1.2 in 2001 to 3.5 in 2010, then did not change significantly from 2010 through 2021 where the rate remained at 4.0」vs 合成阿片率「increased 22%」至 21.8/10 万[一手逐字]——2010 年后死亡主升浪由非法合成阿片驱动，处方类曲线已经走平；CDC 2022 电话会（Jones 语，archive.cdc.gov 200）逐字「actions related to the current state of the overdose crisis, which are very much driven by illicit synthetic opioids like illicitly made fentanyl, resurgent methamphetamine are not the aim of this guideline today」[一手逐字]；USA Today（摘录级）「While prescription painkillers and heroin drove the nation’s overdose epidemic last decade, the powerful synthetic opioid fentanyl is now responsible for most overdose deaths.」[需亲核]——但「唯一祸首」不立的另一面也不是「处方无罪」：NIDA「80% 海洛因使用者先滥用处方阿片」[一手逐字]证明处方是第一波与过渡期的入口——裁决落点：处方是第一波（1990s-2010）的主导驱动，此后被非法市场接管，两个阶段都是真的。

反方四：「危机已解决（罚款/和解/指南都落地了）」——不立。 ①死亡曲线：2021 终值 106,699 → 2023 终值 105,007（仍比 2019 的 70,630 高约 49%——db522 同表逐字）→ 2024 终值 79,384（-26.2% 史上最大降幅，但仍是 2014 年 14.7/10 万时代的 1.57 倍）[一手逐字]——2024 是第一个真拐点，写稿时点必须同时交代「大降」与「仍高」；②曲线分离：处方量 2012 峰值 255,207,954 → 2020 年 142,816,781（-44.0% 自算）同期总死亡从 41,340（2012，db522 表逐字）升至 106,699（2021）——处方收缩与死亡上升反向而行；③和解金执行账：KFF Health News 2025-11-03《Payback: Tracking Opioid Cash》（直连 200）逐字「state and local governments are set to receive more than $50 billion in opioid settlement money」「Nationwide, more than $61 million in opioid settlement funds were spent on law enforcement-related efforts in 2024」「Nearly $2.7 billion—that’s the amount states and localities spent or committed in 2024」「about 20% of it is untrackable through public records」[一手逐字 ×4]——50B 承诺 vs 2024 年 2.7B 支出 vs 20% 不可追踪：和解金落地与危机解决之间隔着执行账；④治理史：2007 认罪后危机继续扩大、2016 指南后死亡继续上升、2020 和解后 2021-2023 仍 10 万+/年——每一次「解决」都发生在下一次峰值之前。

反方五：「止痛治疗已回归正常（cautious prescribing 成功）」——不立（回归有代价，代价是官方自己写下的）。 CDC 2016 指南推荐 5（90 MME）（OCMA 副本 + CDC 2019 新闻稿双源）逐字「When opioids are started, clinicians should prescribe the lowest effective dosage. Clinicians should use caution when prescribing opioids at any dosage…should avoid increasing dosage to ≥90 MME/day or carefully justify a decision to titrate dosage to ≥90 MME/day」[一手逐字]；CDC 2019-04-24 官方新闻稿《CDC Advises Against Misapplication of the Guideline》（archive.cdc.gov 200）逐字「Misapplication of the Guideline’s dosage recommendation that results in hard limits or ‘cutting off’ opioids…The recommendation statement does not suggest discontinuation of opioids already prescribed at higher dosages. The Guideline does not support abrupt tapering or sudden discontinuation of opioids.」[一手逐字]——CDC 自己在 2019 年警告 90 MME 被误用为硬性 cut-off；CDC 2022 指南（PMC 全文）逐字「to discourage the misapplication of opioid pain medication dosage thresholds as inflexible standards, revised recommendation statement language emphasizes principles such as avoiding increasing dosage above levels likely to yield diminishing returns」「Multiple experts from OWG expressed concern that including specific dosage thresholds in a main recommendation statement would emphasize them as authoritative absolutes」「Such misapplication includes…rapid opioid tapers and abrupt discontinuation without collaboration with patients, rigid application of opioid dosage thresholds…patient dismissal and abandonment. These actions are not consistent with the 2016 CDC Opioid Prescribing Guideline and have contributed to patient harm」[一手逐字 ×3]——2022 指南亲手移除了 90 MME 阈值（任务书「no longer include the 90 MME cutoff」以官方句替代），并逐字列出误用后果：患者被弃诊（patient dismissal and abandonment）；HHS Guide 2019（Dowell/Compton/Giroir）（Wayback 200）逐字「There are concerning reports of patients having opioid therapy discontinued abruptly and of clinicians being unwilling to accept new patients who are receiving opioids for chronic pain」「Payer and health system policies that misinterpret cautionary dosage thresholds as mandates for dose reduction may result in rapid tapers or abrupt discontinuation」「clinicians have a responsibility to provide care for or arrange for management of patients’ pain and should not abandon patients」[一手逐字 ×3]；CDC 2022 电话会（Jones 语）逐字「we have seen…patients whose clinicians stop prescribing to them or abandon them from care or rapidly forced them to get too much lower doses of opioids. And there are very real harms…mental health crises, suicidal ideation or behavior…potentially even for some people seeking out opioids through other markets, like illicit markets in order to stave off withdrawal」[一手逐字]；Lagisetty 2019（JAMA Netw Open，Europe PMC 200）逐字「79 (40.7%) stated that their practitioners would not prescribe opioids to the simulated patient」「access to primary care may be reduced for patients taking prescription opioids, which could lead to unintended consequences, such as conversion to illicit substances」[一手逐字]——「回归正常」的官方账：处方量 -44% 是真的（6.3）、被弃诊的患者是真的（40.7% 拒收）、CDC 自己承认的 harm 是真的——「正常」不是无代价的，它以慢性疼痛患者被遗弃为代价。

十、母裁决

「12 小时神话」这句话里，「神话」是真的，「12 小时」是真的——被读成的一句话却是两件不同的事。 那封 101 词的信是真的（Porter & Jick 1980，NEJM 原文逐字，11,882 名住院患者中 4 例成瘾、1 例 major、三个限定词齐全）；那个数字是真的（4/11,882 从未被任何人改过）；那张标签是真的（1995 年「The controlled-release nature of the formulation allows it to be effectively administered every 12 hours」，FDA 批准信与原始标签逐字）；那个营销动作是真的（1998 年预算案「the most compelling reason to prescribe」、销售培训「less than one percent」、2001 年 $200M 营销支出，Van Zee 逐字）；那条法律链是真的（2007 年 $634.5M 认罪「with the intent to defraud or mislead」→ 2020 年 $3.544B+$2B+$2.8B 全球和解「the largest penalties ever levied against a pharmaceutical manufacturer」→ 2024 年最高法院 5-4「The bankruptcy code does not authorize a release and injunction」→ 2025 年 11 月新计划获批「Sackler family…contribute up to $7 billion over 15 years」→ 2026 年 5 月 1 日普渡永久停业）——这一侧一条都不动。 而「成瘾罕见」被读成「长期处方也安全」（Leung 2017：608 篇引用、72.2% 肯定式引用、80.8% 未注明住院语境、「heavily and uncritically cited」——NEJM 编辑部把它写成按语）、「12 小时给药」被读成「12 小时止疼」（标签是「designed to provide delivery…over 12 hours」+ t½ 4.5 小时 + FDA 自己写明「no well-controlled clinical studies」、辩护方论文自认实测 9.6 小时与「twice as likely to use IR rescue」）、「处方阿片是第一波」被读成「处方阿片是全部祸首」（CDC 三波框架逐字：第一波 1990s 处方、第二波 2010 海洛因、第三波 2013 非法芬太尼；处方类死亡率 2010-2021 稳定在 4.0/10 万）——这三个读法，每一个都被官方文件或同行评议自己拆解过。与 PFAS 篇（第 206 篇）的对照在此闭合：那篇的名号是 2018 年造词（「forever chemicals」，M-W 收录时自注 not used technically），本篇的名号是 2016 年命名（「12-hour myth」，LA Times 调查 + CTN 简报 + 学术综述三方合流，任务书预设的 NEJM 2016 观点文章经三重检索确认不存在）——两篇都是「名号是真的、名号所指的实物也是真的、被读成的那个句子是假的」；那篇的尺子是检出/超标/有害三层，本篇的尺子是「住院/短期/无成瘾史」三个限定词——PFAS 的限定词丢在检测层，阿片的限定词丢在引用层，丢法不同，线头都在档案里。

灵魂句：那封信是真的，那个数字是真的，那张标签是真的——被读成的一句假话，是把「住院、短期、无成瘾史」三个限定词从一句话里拆掉的那个动作。拆掉限定词的不是普渡一家——是引用链、是培训材料、是媒体标题、是每一处把 4/11,882 读成「成瘾罕见」的转述。而每个环节的线头，都印在档案里。

附：不确定点与待核对

  1. 「NEJM 2016《The ’12-Hour Myth’》」不存在（任务书预设纠错，最高优先）：PubMed/Crossref/NEJM 目录三重检索零命中；真实命名链为 LA Times 2016-05-05 + CTN Bulletin 2016-12-21 + Van Zee/Leung 学术定案（A/E 捆复核）。
  2. 任务书三个 PMID 全错：7350609（Radiology 论文）应为 7350425；19150908（naloxone 论文）应为 18799767；27959717（EUCLID 试验）对应文章不存在——正文全部用正确记录。
  3. Van Zee DOI：10.2105/AJPH.2007.131714（非任务书 131284）；AJPH 原版正文 403 走 Wayback 302 失败，正文引文以 IJME 2019 再刊版（Van Zee 本人更新）为准并注明版本。
  4. 被引数口径：Semantic Scholar 1084（2026-08-12）≠ Leung 608（截至 2017-03-30 引文分析）——两数并存须注明口径。
  5. 死亡数字层级：2021 终值 106,699（NCHS 2022-12-22 + db457）vs 临时 107,622（2022-05-11 稿）；2022 终值 107,941 vs 预测 109,680；2023 终值 105,007（任务书「107,941 为 2023」系 2022 终值错贴）；2024 终值 79,384（db549/2026-01-29，-26.2% 史上最大）——正文一律终值并注明层级。
  6. 71,238（2021 芬太尼死亡计数）：仅媒体层可证（NBC/USA Today 引 NCHS 临时数据），与终值口径不同，正文避免直接相除；官方比率侧用 db457 逐字。
  7. 「645,000」口径：CDC 原文为「any opioid, including prescription and illicit」——处方+非法合计，不是「处方阿片相关」（C 捆复核 5）。
  8. Shah 2017 在 MMWR 非 JAMA IM；Barnett 卷页 376(7):663-673；「12.6%/1 in 5」「1.7%/0.7%」预设数字未在任何取回件定位——正文用作者手稿实际数字（6.0%/13.5%/29.9%、OR 1.30、7.3% vs 24.1%）。
  9. 「Oxycodone is an opioid agonist 1.5 times more powerful than morphine」：主语是 Oxycodone（活性成分）非 OxyContin（品牌）——正文按官方句引用。
  10. 2007 案金额双口径：$634.5M（公司+三名高管，DOJ 稿）vs $600M（公司+关联方，法院意见/2020 Recital 10）；「largest single criminal fine ever paid by a pharmaceutical company」原句未在已取回文件出现——正文不用该措辞。
  11. Oklahoma v. J&J：$572M 初判已被终局 $465M 取代（法官自纠 $107M→$107,000）——凡引 $572M 必须注明；Teva 全国和解 $4.25B（$5.7B 是 Walgreens）；$26B 框架宣布日 2021-07-21（非 11 月）。
  12. 2025-11 破产案数字口径：总计划 $7.4B（Reuters/AP）vs Sackler up to $7B/15 年（AP/PBS）vs ~$6.5B 分期（Bloomberg T3 未落盘）；「900,000 deaths since 1999」为 AP 2025-11-18 口径（与 CDC 645,000/2021 止、判决书 247,000 处方/2019 止并存，正文并表注明）。
  13. 「every 15 minutes」为 2015 口径（VUMC）；2021 后媒体改用「every 5 minutes」（AP）；中文版「每天坠毁一架波音737」（新华社 2023）——三种换算各有年份，正文注明。
  14. JCAHO「第五生命体征」：2001 实施示例句 2002 即改、2004 删除——正文按 Baker 2017 逐字写「制度史事实」而非「阴谋产物」。
  15. FDA 公告日 2001-07-25（govinfo 听证逐字），非 7-13；2019 标签盒装警告为七项要素（非「五要素」）。
  16. Bodie v. Purdue 引文性质：原告指控转述（上诉法院判词），非事实认定——正文加限定语。
  17. NIDA 两条句分属两个版本（《Misuse of Prescription Drugs》现行页与 2011 研究报告 PDF）——正文注明版本；「addiction is rare among patients who take opioids for acute pain」预设句未取到，用官方实际句。
  18. Sackler 道歉主体：「We are truly sorry」是 Mortimer 分支（2021-09-01）非普渡；「deep sadness」是 David Sackler 听证（2020-12-17）；普渡本尊道歉句现网不存在（2026-05-01 停业）——正文区分主体。

来源清单

（编号来源，按章序；全部链接在正文中已给出。抓取件与逐字核对脚本存 tmp/opioid-audit/raw/（六捆交付文件 rapid_attribution_evidence_A–F.md 同目录），可复现。）

  1. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:123（PubMed 7350425；NEJM 原文 Wayback 20250512123639）— https://web.archive.org/web/20250512123639id_/https://www.nejm.org/doi/full/10.1056/NEJM198001103020221
  2. Leung PTM, Macdonald EM, Stanbrook MB, Dhalla IA, Juurlink DN. A 1980 Letter on the Risk of Opioid Addiction. N Engl J Med 2017;376:2194-2195（PMID 28564561）— https://www.nejm.org/doi/full/10.1056/NEJMc1700150
  3. Van Zee A. The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy. Am J Public Health 2009;99:221-227（PMID 18799767，DOI 10.2105/AJPH.2007.131714）；IJME 2019 再刊版（Van Zee 本人更新；正文 5.3 引文出处）
  4. FDA NDA 20-553 批准信 + 1995 原始标签（regulations.gov FDA-2018-P-2851-0009；jfy 1995 标签副本）— https://downloads.regulations.gov/FDA-2018-P-2851-0009/content.pdf
  5. FDA 2019 OxyContin 标签（022272s043lbl）与 2015 批准史（022272Orig1s027SumR）— https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022272s043lbl.pdf
  6. FDA Timeline of Selected FDA Activities…Opioid Misuse and Abuse（Wayback）— https://web.archive.org/web/2024id_/https://www.fda.gov/media/126835/download
  7. govinfo 众议院听证 CHRG-107hhrg75754（2001-07-25）— https://www.govinfo.gov/content/pkg/CHRG-107hhrg75754/html/CHRG-107hhrg75754.htm
  8. Ryan H, Girion L, Glover S. ‘You Want a Description of Hell?’ OxyContin’s 12-Hour Problem. LA Times 2016-05-05 — https://www.latimes.com/projects/oxycontin-part1/ ；CTN Bulletin 2016-12-21（摘录级）
  9. DOJ 2020-10-21 新闻稿 + 认罪协议（1329576）+ 和解协议（1329571）+ Sackler 和解 — https://www.justice.gov/archives/opa/pr/justice-department-announces-global-resolution-criminal-and-civil-investigations-opioid
  10. Harrington v. Purdue Pharma, 603 U.S. ___ (2024)（23-124_8nk0.pdf）— https://www.supremecourt.gov/opinions/23pdf/23-124_8nk0.pdf
  11. DOJ USAO-WDVA 2007-05-10 新闻稿 + VAWD 法院意见（107CR00029）— https://media.defense.gov/2007/May/10/2001711223/-1/-1/1/purdue_frederick_1.pdf
  12. CDC：Understanding the Opioid Overdose Epidemic（Wayback 2024）、MMWR mm6712a1/mm60e1101a1/mm6626a4/mm6911a4、NCHS Data Brief 457/491/522/549、处方地图页（Wayback 2021）、NCHS 新闻稿 2021-11-17/2022-05-11/2022-12-22/2024-05-15/2025-05-14/2026-01-29
  13. NIDA：Opioid Overdose Crisis（Wayback 2022）、Misuse of Prescription Drugs（现行页）、Prescription Drugs: Abuse and Addiction（2011 PDF）
  14. Shah 2017（MMWR 66(10):265-269，PMC5657867）；Barnett 2017（NEJM 376(7):663-673，PMC5428548）；Juurlink & Dhalla 2012（J Med Toxicol，PMC3550262）
  15. CDC 2016 指南（MMWR 65 RR-1 + OCMA 副本 + CDC 2019 Misapplication 新闻稿）；CDC 2022 指南（MMWR 71 RR-3，PMC9639433）+ 2022-11-03 新闻稿 + 2022-11-09 电话会（archive.cdc.gov）；HHS Guide 2019（stacks.cdc.gov）
  16. Baker 2017（JAMA 317:1117-1118）；VA 1999 疼痛项目新闻稿；Bennett & Carr 2002（J Pain Palliat Care Pharmacother）；Lagisetty 2019（JAMA Netw Open）
  17. Fudin & Raouf 2016（J Pain Res，PMC5019471）；Bodie v. Purdue（11th Cir.，ecases.us）
  18. 2025-11 破产案：Reuters 2025-11-14、AP/PBS 2025-11-18（直连 200 落盘）、purduepharma.com 停业公告（2026-05-01）
  19. 州级：加州 AG 2021-07-21（$26B）与 2023-06-09（四家和解）；AP Oklahoma v. J&J 2019-11-15；KFF Health News 2025-11-03（Payback）
  20. 媒体谱系：HHS 2017-10-26、AP/NBC/NPR 2017-10-26、AP 2022-05-11/2022-12-22、ABC/STAT 2024-05-15、CBS 2016-05-10、VUMC
  21. 中文：新华社 2018-06-21/2023-09-20/2023-09-26、澎湃 2021-12-21 ×2、腾讯/知识分子 2021-06-23、中国药房 2023-05-11、丁香园 2016-06-17、中国日报 2024-08-15、VOA 中文 2019-09-17、人民日报
  22. 影视书籍：Wikipedia（Dopesick/Painkiller/Crime of the Century/Empire of Pain）、Business Wire Sackler 声明 2021-09-01、AP/PBS Sackler 听证 2020-12-17、AEI Satel、Cato 2019、America Magazine 2018
  23. 中国官方：芬太尼类物质整类列管公告（新华社通稿 + 国新办实录）；PubMed 31759032（中美消耗对照）
标签: